---
title: "CHRNG"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "# Gene: CHRNG"
tags: ['GeneCHRNG', 'NicotinicAcetylcholineReceptor', 'MissenseVariant', 'MultiplePterygiumSyndrome', 'LethalType', 'SupportiveTreatment', 'PoorPrognosis', 'RadiologyCaseReport']
---

# Gene: CHRNG

### Function for gene
CHRNG is a protein-coding gene that encodes for the gamma subunit of the nicotinic acetylcholine receptor, which plays a role in synaptic transmission.

### External IDs for gene and genomic location, Aliases
- HGNC: 1953
- Ensembl: ENSG00000214407
- NCBI Entrez: 1144
- Genomic location: Chromosome 2
- Aliases: N/A

### External sites are HGNC, NCBI Entrez, Ensembl, OMIM, UniProtKB/Swiss-Prot
- HGNC: [Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1953)
- NCBI Entrez: [Click](https://www.ncbi.nlm.nih.gov/gene/1144)
- Ensembl: [Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000214407;r=2:233,862,535-233,881,196)
- OMIM: [Click](https://www.omim.org/entry/100730)
- UniProtKB/Swiss-Prot: [Click](https://www.uniprot.org/uniprot/P07510)

### AA mutation list and mutation type with dbSNP ID
- p.Leu273Val - Missense Variant - dbSNP ID: rs116145981

### Somatic SNVs/InDels with dbSNP ID
- N/A

### Related disease
- Multiple pterygium syndrome, lethal type (OMIM: 253290)

### Treatment and prognosis
- There is currently no cure or specific treatment for multiple pterygium syndrome, lethal type. Management is supportive and may include surgery to correct contractures.
- Prognosis is poor, as the condition is often lethal early in life.

### Drug response
- N/A

### Subject, author name, DOI links to related papers
- Jackman, A. et al. (2016) 'Multiple pterygium syndrome: A case report', Radiology Case Reports, 11(2), pp. 129-132. doi: 10.1016/j.radcr.2016.01.005. 

Note: This is not an exhaustive list of all information related to the CHRNG gene. Further research may be necessary for a comprehensive understanding.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**